The anti-CD52 monoclonal antibody alemtuzumab consistently outperforms interferon beta1a (IFN-beta1a) across a range of multiple sclerosis (MS) patient subgroups in terms of freedom from clinical disease activity and reduction of disability, a post-hoc analysis of the CAMMS223 study has revealed....
P. et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 488, 508–511 (2012). This study reveals why anti-TNF therapy for MS causes disease worsening, in contrast to the benefits observed in treating other autoimmune diseases. PubMed PubMed ...
Find all the latest on multiple sclerosis at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.
BACKGROUND: In 2002, the UK's National Institute for Clinical Excellence (NICE) concluded that interferon beta and glatiramer acetate would be cost effective as disease-modifying therapies (DMTs) for multiple sclerosis only if the short-term disability benefits reported in clinical trials were maintai...
The AJMC® Multiple Sclerosis compendium is a comprehensive resource for clinical news and expert insights for the disabling disease that impacts the brain and spinal cord.
VIDEOS ON DEMAND: Multiple sclerosis: What is the evidence for the benefits of a low-sodium diet?doi:10.1097/01.NT.0000460882.80898.65Neurology Today
The success of a clinical trial is often dependant on whether recruitment targets can be met in the required time frame. Despite an increase in research into the benefits of exercise in people with multiple sclerosis (PwMS), no trial has reported detaile
A new drug for multiple sclerosis can dramatically reduce the chances of a relapse or a deterioration of the condition, according to a new study from researchers at Queen Mary, University of London.
Benefits of Mindfulness Erika Lyons RichardsonJuly 13, 2018 0 Practices for Improving Emotional and Physical Well-Being It’s a busy world. You fold the laundry while... Multiple Sclerosis Painters, hair stylists, interior decorators and cleaners can be at higher risk for disease development if ...
Exercise training is a promising second-line treatment approach for wheelchair users with multiple sclerosis (MS), given the limited options for medical management of MS. The aim of the current chapter is to summarize the benefits and safety of exercise training and provide recommendations for the ...